Immune Response Clinical Trial
Official title:
Differences in Susceptibility to SARS CoV-2 Infection According to ACE2 and CD26 Receptors, Specific CD4/CD8 T Cell Response to Viral Peptides, and KIR Receptors Among Health Care Workers Highly Exposed to Patients With COVID-19 Diagnosis.
The primary objective of this study is to establish differences in susceptibility to SARS CoV-2 infection among health care workers (HCW) highly exposed to patients with COVID-19 diagnosis. To ascertain this issue, we evaluated: - Changes in receptor polymorphism (ACE2 and CD26 receptor study. - SARS-CoV-2 CD4/CD8 T cell response (CTL) - Different KIR phenotypes
Only 24% of health care workers (HCW) had developed inmunological response to SARS CoV-2 infection in one centre attending thousands of COVID-19 patients, and with shorteness of personal protective equipments. Our hypothesis is that this relatively low number of infected HCW could be secondary to: 1. Differences in susceptibility to infection mediated by changes in viral receptors. Thus, it is important to characterize and genotyping the main receptor for SARS-CoV-2, ACE2, and other related receptor, such as CD26. 2. Increased cellular immune response, offering cross-immunity against SARS CoV-2 infection by previous exposure to other coronavirus or respiratory pathogens. A specific CD4/CD8 T cell response to viral peptides could respond this question 3. Specific KIR phenotypes (Killer Immunoglobulin-like Receptors): Natural killer cells (NK) response to alterations of class I HLA molecules presented in infected cells. An increase in class I HLA expression could lead to an increase in NK activation by increasing its ability to produce IFN-gamma. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05515263 -
Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination
|
N/A | |
| Completed |
NCT02872311 -
Open-Label Influenza Vaccine Evaluation
|
N/A | |
| Completed |
NCT01861613 -
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
|
Phase 4 | |
| Completed |
NCT03982069 -
Immunologic Response to FluMist vs. Flucelvax
|
Phase 4 | |
| Recruiting |
NCT06041867 -
Agaricus Bisporus and Influenza Vaccination Response
|
N/A | |
| Completed |
NCT03614975 -
Immunologic Response to Influenza Vaccination in Children and Adolescents
|
Phase 4 | |
| Completed |
NCT04573543 -
The Role of Immune Semaphorins in NAFLD
|
||
| Recruiting |
NCT03875703 -
Post-Vaccination Biological Collection
|
||
| Completed |
NCT00902278 -
Immune Responses Induced by Different Licensed Influenza Vaccines
|
N/A | |
| Completed |
NCT00346619 -
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
|
Phase 1 | |
| Recruiting |
NCT04274348 -
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
|
N/A | |
| Active, not recruiting |
NCT05534893 -
Effect of Blueberries on Immunity and Response to Flu Vaccination
|
N/A | |
| Completed |
NCT05970887 -
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
|
Phase 4 | |
| Completed |
NCT05706350 -
Plant Stanol Esters and Influenza Vaccination
|
N/A | |
| Completed |
NCT03167593 -
Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.
|
Phase 2 | |
| Completed |
NCT04386408 -
Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections
|
Phase 1 | |
| Completed |
NCT02933931 -
Immune Durability After VSV-EBOV Vaccination
|
||
| Recruiting |
NCT01289535 -
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
|
Phase 4 | |
| Active, not recruiting |
NCT02441426 -
Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development
|
N/A | |
| Recruiting |
NCT03399357 -
Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial
|
N/A |